Pediatric Nephrology, Dialysis and Transplantation Unit - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Commenda 9, 20122, Milan, Italy.
Department of Radiology - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Commenda 9, 20122, Milan, Italy.
Eur J Pediatr. 2018 Sep;177(9):1383-1388. doi: 10.1007/s00431-018-3087-0. Epub 2018 Feb 1.
It is well known that the nephron endowment of healthy subjects is highly variable and that individual nephron mass has potentially important implications both in health and disease. However, nephron count is technically impossible in living subjects. Based on the observation of an increase in serum creatinine (sCr) in otherwise healthy newborns with solitary kidney during the physiological perinatal dehydration, we hypothesized that perinatal sCr might be helpful in identifying healthy subjects with a reduced nephron mass. In the framework of a study on blood pressure in babies (NeoNeph), sCr of normal Caucasian neonates was determined 48-96 h after birth and their association with a family history of arterial hypertension (AH) was analyzed. SCr was determined in 182 normal newborns (90 males) at a mean of 61 ± 8 h after birth (range 46-82). Newborns with paternal AH had a higher mean sCr (0.97 + 0.28 mg/dL) then newborns without paternal AH (0.73 + 0.28 mg/dL; p = 0.006). No differences in mean sCr were found in relation with mother or grandparent's history of AH.
The association between parental AH and high sCr during perinatal dehydration supports the hypothesis that the latter is a promising tool for identifying normal subjects with a reduced nephron mass with potential important implications in prevention and in understanding the individual outcome of renal and extrarenal diseases (including AH). What is Known: • Nephron endowment of healthy subjects is highly variable and individual nephron mass has potentially important implications both in health and disease however nephron count is not feasible in living subjects. What is New: • Serum creatinine during perinatal dehydration is a possible biomarker for identifying normal subjects with a reduced nephron mass.
众所周知,健康受试者的肾单位数量存在很大的可变性,个体肾单位数量在健康和疾病方面都具有潜在的重要意义。然而,活体受试者的肾单位计数在技术上是不可能的。基于在生理围产期脱水的单肾健康新生儿中观察到血清肌酐(sCr)升高的现象,我们假设围产期 sCr 可能有助于识别肾单位数量减少的健康受试者。在一项关于婴儿血压的研究(NeoNeph)中,我们在出生后 48-96 小时测定了正常白种新生儿的 sCr,并分析了其与家族性高血压(AH)病史的关系。在这项研究中,我们在 182 名正常新生儿(90 名男性)中测定了 sCr,平均出生后 61±8 小时(范围 46-82 小时)。有父亲 AH 病史的新生儿 sCr 平均值(0.97±0.28mg/dL)高于无父亲 AH 病史的新生儿(0.73±0.28mg/dL;p=0.006)。与母亲或祖母的 AH 病史无关。
围产期脱水时父母 AH 与高 sCr 的关系支持这样一种假设,即后者是一种很有前途的工具,可以识别肾单位数量减少的正常受试者,这在预防和理解肾脏和肾脏以外疾病(包括 AH)的个体预后方面具有潜在的重要意义。
健康受试者的肾单位数量存在很大的可变性,个体肾单位数量在健康和疾病方面都具有潜在的重要意义,但是活体受试者的肾单位计数是不可行的。
围产期脱水时的血清肌酐可能是识别肾单位数量减少的正常受试者的生物标志物。